Q: Hi 5i team,
Last week was about the 4th big rotation from growth to value this year. This morning Moderna announced success with its vaccine. All the fund managers are now adding extra 10 lb. value weights to their barbells. My barbell has been heavy on the growth side. While you often give target sector weightings, you don’t tend to do it between growth versus value. I know you are growth managers for the most part but does this 2nd vaccine and change in market sentiment now give you pause to consider placing more of a value tilt on one’s portfolio?
Thanks again for the insight.
Dave
Last week was about the 4th big rotation from growth to value this year. This morning Moderna announced success with its vaccine. All the fund managers are now adding extra 10 lb. value weights to their barbells. My barbell has been heavy on the growth side. While you often give target sector weightings, you don’t tend to do it between growth versus value. I know you are growth managers for the most part but does this 2nd vaccine and change in market sentiment now give you pause to consider placing more of a value tilt on one’s portfolio?
Thanks again for the insight.
Dave